Renal hyperparathyroidism (rHPT) develops during the early stages of renal failure with high risks of bone fractures, CVD, and death [13,14]. PTH and FGF-23 increase as kidney function declines, and when patients reach kidney failure, they fail to exert their phosphaturic effects. The gene discussed is FGF23; the disease is Renal insufficiency.